Fundies. English
Segment disclosures
Company overviewCHINA JO-JO DRUGSTORES, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
70 dimension combinations 768 retained observations 20 reported periods Partial retained history
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Medical Devices · Online Pharmacy
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 3464638 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 3280060 | USD | 20210629 | Open filing evidence |
Medical Devices · Retail Drugstores
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 5607506 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 3852643 | USD | 20210629 | Open filing evidence |
Medical Devices · Wholesale
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 431230 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 86184 | USD | 20210629 | Open filing evidence |
Nutritional Supplements · Online Pharmacy
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 956013 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 742809 | USD | 20210629 | Open filing evidence |
Nutritional Supplements · Retail Drugstores
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 6863559 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 6013622 | USD | 20210629 | Open filing evidence |
Nutritional Supplements · Wholesale
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 151657 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 205881 | USD | 20210629 | Open filing evidence |
OTC Drugs · Online Pharmacy
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:OTCDrugsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 7559585 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 5721638 | USD | 20210629 | Open filing evidence |
OTC Drugs · Retail Drugstores
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:OTCDrugsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 30524057 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 31532248 | USD | 20210629 | Open filing evidence |
OTC Drugs · Wholesale
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:OTCDrugsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 6242630 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 4196841 | USD | 20210629 | Open filing evidence |
Prescription Drugs · Online Pharmacy
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 8243099 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 1447469 | USD | 20210629 | Open filing evidence |
Prescription Drugs · Retail Drugstores
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 27162968 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 26045423 | USD | 20210629 | Open filing evidence |
Prescription Drugs · Wholesale
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 27477087 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 24857708 | USD | 20210629 | Open filing evidence |
Sundry Products · Online Pharmacy
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:SundryProductsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 1967174 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 2082601 | USD | 20210629 | Open filing evidence |
Sundry Products · Retail Drugstores
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:SundryProductsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 1379917 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 1312293 | USD | 20210629 | Open filing evidence |
Sundry Products · Wholesale
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:SundryProductsMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 28377 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 43854 | USD | 20210629 | Open filing evidence |
TCM · Online Pharmacy
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:TCMMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 295410 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 266638 | USD | 20210629 | Open filing evidence |
TCM · Retail Drugstores
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:TCMMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 4560968 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 5325008 | USD | 20210629 | Open filing evidence |
TCM · Wholesale
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=cjjd:TCMMember;us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 218758 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 314769 | USD | 20210629 | Open filing evidence |
Drug Wholesale
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 34549739 | USD | 20210629 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 8872781 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 23768822 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 17930496 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 36740970 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7331004 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 29705237 | USD | 20210629 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 7822294 Restated | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 21925727 Restated | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 18001273 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 34736261 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 6102191 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 72334409 Restated | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 20867249 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 54971889 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 7149900 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 11932256 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 4782356 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 22002194 Restated | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 5128973 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 16021694 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 5378412 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 10892721 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5514309 | USD | 20180814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 14321663 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 3051086 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 9777803 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 3570123 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 6726717 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 3156594 | USD | 20170814 | Open filing evidence |
Drug Wholesale · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 1483645 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 4623405 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1273876 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 3139760 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1865884 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 3852643 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 611597 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 2370604 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 592914 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 1759007 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1166093 Restated | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 3591646 Restated | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 1257180 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 2953326 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 47984 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 83898 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 35914 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 32 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 7682 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 47476 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 39794 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 39794 | USD | 20181114 | Open filing evidence |
Drug Wholesale · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 1624313 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 4636347 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1664265 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 3012034 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1347769 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 6013622 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1602407 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 4510514 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1676974 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 2908107 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1231133 Restated | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 6354108 Restated | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 1869351 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 4750013 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 48216 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 73597 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 25381 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 182903 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 19123 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 47660 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 12279 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 28537 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 16258 | USD | 20180814 | Open filing evidence |
Drug Wholesale · OTC Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:OTCDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 8451389 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 22887032 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 7617159 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 14435643 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 6818484 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 31532248 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 10260883 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 24964312 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 7463201 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 14703429 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 7240228 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 31401328 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 9393148 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 24018263 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2629761 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 3904680 | USD | 20191114 | Open filing evidence |
Drug Wholesale · Over Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:OverCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-04-01 – 2019-06-30 | 1074261 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 8964587 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 3341676 | USD | 20190214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 7246356 | USD | 20190214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2629761 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 3904680 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1274919 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 9381932 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 2303726 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 6652879 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 2248503 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 4349153 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 2100650 | USD | 20180814 | Open filing evidence |
Drug Wholesale · Prescription Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 7013958 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 20403438 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 5982706 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 13389480 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7406774 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 26045423 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 7496469 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 19214689 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 6022934 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 11718220 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5695286 Restated | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 23516046 Restated | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 6756073 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 17835700 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 4355706 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 7775242 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 3419536 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 12314829 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 2777566 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 9252199 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 3077232 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 6474633 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 3397401 | USD | 20180814 | Open filing evidence |
Drug Wholesale · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 301658 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 1062321 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 338112 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 760663 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 422551 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 1312293 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 188484 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 777432 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 290750 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 588948 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 298198 Restated | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 941491 Restated | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 248729 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 799554 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 10775 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 15530 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 4755 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 48852 | USD | 20190701 | Open filing evidence |
Drug Wholesale · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;srt:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 1191877 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 3195267 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1054378 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 2003390 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 949012 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 5325008 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1416126 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 4474676 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1954500 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 3058550 Restated | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1104050 Restated | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 6529790 Restated | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 1342768 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 4615033 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 57458 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 79309 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 21851 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 73645 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 20876 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 21480 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 604 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 604 | USD | 20181114 | Open filing evidence |
Drug Wholesale · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 32 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 7682 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 47476 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 39794 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 39794 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 914 | USD | 20180629 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 921 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 165 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 931 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 766 | USD | 20170814 | Open filing evidence |
Drug Wholesale · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 182903 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 19123 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 47660 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 12279 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 28537 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 16258 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 57086 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 15110 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 49929 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 31170 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 70493 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 39323 | USD | 20170814 | Open filing evidence |
Drug Wholesale · Over Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:OverCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 9381932 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 2303726 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 6652879 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 2248503 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 4349153 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 2100650 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 6086768 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 1127918 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 3967959 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1621129 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2840030 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1218901 | USD | 20170814 | Open filing evidence |
Drug Wholesale · Over The Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:OverTheCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 1621129 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2840030 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1218901 | USD | 20160815 | Open filing evidence |
Drug Wholesale · Prescription Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 12314829 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 2777566 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 9252199 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 3077232 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 6474633 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 3397401 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 7967911 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 1907318 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 5753801 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1948879 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 3846484 Restated | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1897605 Restated | USD | 20170814 | Open filing evidence |
Drug Wholesale · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 48852 | USD | 20180629 | Open filing evidence |
Drug Wholesale · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:DrugWholesaleMember;us-gaap:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 73645 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 20876 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 21480 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 604 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 604 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 208984 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 740 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 5193 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 4453 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 4453 | USD | 20171114 | Open filing evidence |
Online Pharmacy
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 22485919 | USD | 20210629 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 6599138 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 16858984 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 5347012 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 10259846 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4912834 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 13541215 | USD | 20210629 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 3965023 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 8759892 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2351264 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 4794869 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2443605 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 8784459 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 2493206 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 6637922 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2122848 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 4144717 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2021869 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 12132930 Restated | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 3395047 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 9595752 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 3065016 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 6200705 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 3135689 | USD | 20180814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 15388996 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 3437371 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 12292175 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 3783725 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 8854804 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 5071079 | USD | 20170814 | Open filing evidence |
Online Pharmacy · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 915414 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 2758401 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 913557 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 1842987 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 929430 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 3280060 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 966393 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 2517455 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 691670 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 1551062 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 859392 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 2108836 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 832526 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 1467304 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 574094 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 634779 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 60685 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 1096849 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1111396 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 3106325 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 911741 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 1994929 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1083188 | USD | 20180814 | Open filing evidence |
Online Pharmacy · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 318869 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 747962 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 208062 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 3305845 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 221031 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 742809 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 245249 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 488956 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 136513 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 243707 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 107194 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 737315 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 220776 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 575862 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 211990 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 355086 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 143096 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 29717 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 514952 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 1365834 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 334806 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 850882 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 516076 | USD | 20180814 | Open filing evidence |
Online Pharmacy · OTC Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:OTCDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 2415029 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 5720874 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1983034 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 3305845 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1322811 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 5721638 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1981871 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 4133128 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1126655 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 2151257 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1024602 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 3127976 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 837126 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 2412057 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 798938 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 1574931 | USD | 20191114 | Open filing evidence |
Online Pharmacy · Over Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:OverCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-04-01 – 2019-06-30 | 1024602 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 3127976 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 837126 | USD | 20190214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 2412057 | USD | 20190214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 798938 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 1574931 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 775993 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 5193051 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1535383 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 4038674 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1385899 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 2503291 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1117392 | USD | 20180814 | Open filing evidence |
Online Pharmacy · Prescription Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 2227332 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 5855491 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1758516 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 3628159 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1869643 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 1447469 | USD | 20200710 | Open filing evidence |
Online Pharmacy · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 548018 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 1506232 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 411494 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 958214 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 546720 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 2082601 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 729179 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 1542372 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 374457 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 813193 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 438736 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 2736070 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 573993 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 2128282 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 517123 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 1554289 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1037166 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 1880707 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 224514 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 1065935 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 422388 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 841421 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 419033 | USD | 20180814 | Open filing evidence |
Online Pharmacy · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;srt:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 174476 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 270024 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 72349 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 3305845 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 23199 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 266638 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 42331 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 77981 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 21969 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 35650 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 13681 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 74262 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 28785 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 54417 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 20703 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 25632 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 4929 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 3932607 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 8802 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 18984 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 10182 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 10182 | USD | 20181114 | Open filing evidence |
Online Pharmacy · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;us-gaap:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 1096849 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1111396 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 3106325 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 911741 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 1994929 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1083188 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 5850671 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 1378568 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 4770954 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1532784 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 3392386 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1859602 | USD | 20170814 | Open filing evidence |
Online Pharmacy · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;us-gaap:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 29717 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 514952 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 1365834 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 334806 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 850882 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 516076 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 2287756 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 407815 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 1852294 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 536456 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 1444479 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 908023 | USD | 20170814 | Open filing evidence |
Online Pharmacy · Over Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;us-gaap:ProductOrServiceAxis=cjjd:OverCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 5193051 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1535383 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 4038674 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1385899 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 2503291 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1117392 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 5292056 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 1211013 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 4157448 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1309143 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2946434 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1637291 | USD | 20170814 | Open filing evidence |
Online Pharmacy · Over The Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;us-gaap:ProductOrServiceAxis=cjjd:OverTheCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 1309143 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2946434 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 1637291 | USD | 20160815 | Open filing evidence |
Online Pharmacy · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;us-gaap:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 1880707 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 224514 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 1065935 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 422388 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 841421 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 419033 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 1957391 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 438845 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 1510349 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 405341 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 1071504 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 666163 | USD | 20170814 | Open filing evidence |
Online Pharmacy · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:OnlinePharmacyMember;us-gaap:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 3932607 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 8802 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 18984 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 10182 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 10182 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 1122 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 1130 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 1130 | USD | 20180214 | Open filing evidence |
Retail Drugstores
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailDrugstoresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 76098975 | USD | 20210629 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 74081237 | USD | 20210629 | Open filing evidence |
Retail Store
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 20066840 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 56807810 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 17930496 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 36740970 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 18810474 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 74081237 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 21575965 Restated | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 56312226 Restated | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 18001273 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 34736261 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 16734988 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 72334409 | USD | 20200710 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 7556094 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 19488350 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 18136298 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 34104639 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 15968341 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 61977582 Restated | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 18288222 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 46356207 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 15047615 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 28067985 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 13020370 | USD | 20180814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 51788386 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 14121567 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 39636796 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 12806987 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 25515229 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 12078242 Restated | USD | 20170814 | Open filing evidence |
Retail Store · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-10-01 – 2019-12-31 | 18303 | USD | 20200214 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 54690 | USD | 20200214 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 592914 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 1759007 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1166093 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 3591646 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 30743 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 114641 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1234482 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 1696145 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 461663 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 962619 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 497282 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 1402760 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 436303 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 905478 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 469175 | USD | 20180814 | Open filing evidence |
Retail Store · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-10-01 – 2019-12-31 | 47736 | USD | 20200214 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 104475 | USD | 20200214 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1676974 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 2908107 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1231133 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 6354108 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 167069 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 240666 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1935456 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 2880662 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 945206 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 4179139 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1883020 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 4558383 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1638031 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 2675363 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1037332 | USD | 20180814 | Open filing evidence |
Retail Store · OTC Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:OTCDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-10-01 – 2019-12-31 | 1310927 | USD | 20200214 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 3433730 | USD | 20200214 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 7463201 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 14703429 | USD | 20191114 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 3341676 | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 7246356 | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 7660287 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 14625115 | USD | 20191114 | Open filing evidence |
Retail Store · Over Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:OverCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-04-01 – 2019-06-30 | 7240228 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 31401328 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 9393148 | USD | 20190214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 24018263 | USD | 20190214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 7660287 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 14625115 | USD | 20181114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 6964828 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 28368059 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 9168708 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 21593385 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 6780715 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 12424677 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5643962 | USD | 20180814 | Open filing evidence |
Retail Store · Prescription Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-10-01 – 2019-12-31 | 6358031 | USD | 20200214 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 18054557 | USD | 20200214 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 6022934 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 11718220 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5695286 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 23516046 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 3933441 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 11708683 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 5270412 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 11079627 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5809215 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 20553179 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 5373870 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 14860659 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 4891435 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 9486789 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 4595354 | USD | 20180814 | Open filing evidence |
Retail Store · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-10-01 – 2019-12-31 | 19789 | USD | 20200214 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 30809 | USD | 20200214 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 290750 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 813193 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 298198 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 941491 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 5949 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 21479 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 345964 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 1554289 Restated | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 204861 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 6254286 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 180338 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 804817 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 362443 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 624479 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 262036 | USD | 20180814 | Open filing evidence |
Retail Store · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;srt:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-10-01 – 2019-12-31 | 67507 | USD | 20200214 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 247465 | USD | 20200214 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1954500 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 3058550 | USD | 20191114 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1104050 | USD | 20190814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 6529790 | USD | 20190701 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 77216 Restated | USD | 20200214 | Open filing evidence |
| 2018-04-01 – 2018-12-31 | 156525 Restated | USD | 20200214 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1689697 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-09-30 | 3272265 | USD | 20191114 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1582568 | USD | 20190814 | Open filing evidence |
| 2017-04-01 – 2018-03-31 | 1660301 | USD | 20190701 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1185004 | USD | 20190214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 3136203 | USD | 20190214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 938688 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 1951199 | USD | 20181114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1012511 | USD | 20180814 | Open filing evidence |
Retail Store · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 962619 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 497282 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 1402760 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 436303 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 905478 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 469175 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 3078673 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 308143 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 2685640 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1176034 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2377497 | USD | 20171114 | Open filing evidence |
Retail Store · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 4179139 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1883020 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 4558383 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 1638031 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 2675363 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1037332 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 4197001 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 896122 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 3073882 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 965346 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2142086 | USD | 20171114 | Open filing evidence |
Retail Store · Over Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:OverCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 28368059 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 9168708 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 21593385 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 6780715 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 12424677 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5643962 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 22392071 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 7053888 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 17117444 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 5188201 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 10063556 | USD | 20171114 | Open filing evidence |
Retail Store · Over The Counter Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:OverTheCounterDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2016-07-01 – 2016-09-30 | 5188201 | USD | 20161114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 10063556 | USD | 20161114 | Open filing evidence |
Retail Store · Prescription Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 20553179 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 5373870 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 14860659 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 4891435 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 9486789 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 4595354 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 17104240 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 4469589 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 12837817 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 4097127 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 8368229 | USD | 20171114 | Open filing evidence |
Retail Store · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 6254286 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 180338 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 804817 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 362443 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 624479 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 262036 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 876184 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 236152 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 714509 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 223799 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 478357 | USD | 20171114 | Open filing evidence |
Retail Store · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:RetailStoreMember;us-gaap:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2017-04-01 – 2018-03-31 | 1660301 | USD | 20180629 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 1185004 | USD | 20180214 | Open filing evidence |
| 2017-04-01 – 2017-12-31 | 3136203 | USD | 20180214 | Open filing evidence |
| 2017-07-01 – 2017-09-30 | 938688 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-09-30 | 1951199 | USD | 20171114 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 1012511 | USD | 20170814 | Open filing evidence |
| 2016-04-01 – 2017-03-31 | 4140217 | USD | 20180629 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 1157673 | USD | 20180214 | Open filing evidence |
| 2016-04-01 – 2016-12-31 | 3207504 | USD | 20180214 | Open filing evidence |
| 2016-07-01 – 2016-09-30 | 1120808 | USD | 20171114 | Open filing evidence |
| 2016-04-01 – 2016-09-30 | 2049831 | USD | 20171114 | Open filing evidence |
Wholesale
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2021-03-31 | 34549739 | USD | 20210629 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 8872781 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 23768822 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 7565037 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 14896041 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7331004 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 29705237 | USD | 20210629 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 7822293 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 21925726 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 8001242 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 14103433 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 6102191 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 26432144 | USD | 20200710 | Open filing evidence |
Wholesale · Medical Devices
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember;srt:ProductOrServiceAxis=cjjd:MedicalDevicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 20590 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 406124 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 27229 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 385534 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 358305 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 86184 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 18303 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 54690 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 15149 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 36387 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 21238 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 24846 | USD | 20200710 | Open filing evidence |
Wholesale · Nutritional Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember;srt:ProductOrServiceAxis=cjjd:NutritionalSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 15452 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 102397 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 27104 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 86945 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 59841 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 205881 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 47736 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 104475 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 35048 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 56739 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 21691 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 290534 | USD | 20200710 | Open filing evidence |
Wholesale · OTC Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember;srt:ProductOrServiceAxis=cjjd:OTCDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 1326118 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 3804608 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1563344 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 2478490 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 915146 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 4196841 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1310927 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 3433730 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1048542 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 2122803 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1074261 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 8964587 | USD | 20200710 | Open filing evidence |
Wholesale · Prescription Drugs
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember;srt:ProductOrServiceAxis=cjjd:PrescriptionDrugsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 7450847 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 19267262 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 5850267 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 11816415 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5966148 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 24857708 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 6358031 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 18054557 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 6816035 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 11696526 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 4880491 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 16745862 | USD | 20200710 | Open filing evidence |
Wholesale · Sundry Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember;srt:ProductOrServiceAxis=cjjd:SundryProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 2530 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 23887 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 18760 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 21357 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2597 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 43854 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 19789 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 30809 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 5338 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 11020 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5682 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 24846 | USD | 20200710 | Open filing evidence |
Wholesale · Traditional Chinese Medicine
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cjjd:WholesaleMember;srt:ProductOrServiceAxis=cjjd:TraditionalChineseMedicineMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2020-12-31 | 57244 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 164544 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 78333 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 107300 | USD | 20201113 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 28967 | USD | 20200814 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 314769 | USD | 20200710 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 67507 | USD | 20210212 | Open filing evidence |
| 2019-04-01 – 2019-12-31 | 247465 | USD | 20210212 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 81130 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-09-30 | 179958 | USD | 20201113 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 98828 | USD | 20200814 | Open filing evidence |
| 2018-04-01 – 2019-03-31 | 271280 | USD | 20200710 | Open filing evidence |